The leading global voice
We play a major role in bringing the CV community together to drive transformational change.
Together we are stronger
By 2025, our aim is to reduce premature deaths from CVD by at least 25%.
Join the fight
Become a WHF member and help us to build global commitment to address cardiovascular health at the policy level.
We convene and connect our members
To share science, best practice and resources, acting as a global thought leader and catalyst for positive change.
Celebrate World Heart Day
The biggest global awareness-raising campaign for CVD.
Attend the Congress
Join world leaders in heart health, share ideas, network with specialists.
Advocating for heart health
We lead the global advocacy effort for action to prevent, control and reduce the global burden of CVD.
All our programmes and partnerships are aimed at creating awareness of CVD as a priority issue across the globe.
Find out more about our and our members' work around the world.
Explore everything from toolkits, videos and infographics, to policy reports, factsheets and more.
The World Heart Federation’s Cholesterol Roadmap is being previewed today at the American Heart Association (AHA) Scientific Sessions 2016 in New Orleans, USA.
In the Roadmap the WHF calls for more awareness of healthier lifestyles and diet; increased screening and testing for cholesterol in communities; more effective initiation of statin treatment and adherence to drug treatments in primary and secondary prevention of CVD; better detection and treatment of patients with familial hypercholesterolaemia (FH); better physician education and support; and reform of drug availability and affordability.
The Cholesterol Roadmap forms part of a series produced by WHF to help meet targets set by the World Health Organization (WHO) to reduce premature deaths from non-communicable diseases, including cardiovascular disease (CVD), by 25% by 2025. Reducing the risk of cholesterol-related CVD has an essential role to play in achieving this goal. Previous WHF Roadmaps have focused on secondary prevention, hypertension (primary prevention), tobacco control, rheumatic heart disease and non-valvular atrial fibrillation, the most common form of cardiac arrhythmia.